The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Abstract
Patients with hypopituitarism develop a phenotype similar to metabolic syndrome with central obesity and diabetes. Similarly, patients with hypothalamic damage may develop central obesity, insulin resistance, and hyperphagia. We sought to examine the clinical associations between hypopituitarism, hypothalamic dysfunction, and nonalcoholic fatty liver disease (NAFLD). A case series of patients seen at our institution with diagnoses of hypopituitarism, hypothalamic obesity, or craniopharyngioma and NAFLD was undertaken. Clinical, laboratory, and liver biopsy features were reviewed. Twenty-one patients were identified. NAFLD was diagnosed 6.4 ± 7.5 years (median 3 years) after the diagnosis of hypothalamic/pituitary dysfunction. Mean gain in body mass index (BMI) between diagnoses of hypothalamic/pituitary disease and NAFLD was 11.3 ± 8.9 kg/m 2 at an average yearly rate of 2.2 ± 2.2 kg/m 2. The majority of patients developed elevated glucose levels and dyslipidemia by time of diagnosis of NAFLD. Of the 10 patients biopsied, six were cirrhotic, two had nonalcoholic steatohepatitis (NASH) with fibrosis, and two had simple steatosis. Long-term follow-up of 66 ± 33 months (range 12-120) was available for 18 patients. Two required liver transplantation. Six patients died, two from liver related causes. In conclusion, patients with hypothalamic and/or pituitary disease are at risk of excessive weight gain, impaired glucose tolerance, and dyslipidemia with subsequent development of NAFLD. This group has a high prevalence of cirrhosis placing them at risk for liver-related death. The novel evidence that hypothalamic/pituitary dysfunction may be accompanied by progressive NAFLD has important implications for the work-up and management of patients with hypothalamic/pituitary disease. (Hepatology 2004;39:909-914.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Self-citationNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Leptin regulates proinflammatory immune responses
Loffreda, S., Yang, S. Q., Lin, H. Z., Karp, C. L., Brengman, M. L., Wang, D. J., Klein, A. S., Bulkley, G. B., Bao, C., Noble, P. W., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.57 · Cited by 1,251
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo-Perin, P., & Rizzetto, M. (2002) · Hepatology · doi:10.1053/jhep.2002.30690 · Cited by 753
Mechanism of the development of obesity in animals with hypothalamic lesions.
Brobeck, J. R. (1946) · Physiological Reviews · doi:10.1152/physrev.1946.26.4.541 · Cited by 488
Systemic Inflammation, Adipose Tissue Tumor Necrosis Factor, and Leptin Expression
Bulló, M., García‐Lorda, P., Megias, I., & Salas‐Salvadó, J. (2003) · Obesity Research · doi:10.1038/oby.2003.74 · Cited by 449
Koteish, A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 445
Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y.-J., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 385
Saxena, N. K., Ikeda, K., Rockey, D. C., Friedman, S. L., & Anania, F. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32029 · Cited by 382
The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis
Holt, R. I. G., Simpson, H. L., & Sönksen, P. H. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00827.x · Cited by 191
ZELMAN, S. (1952) · Archives of Internal Medicine · doi:10.1001/archinte.1952.00240080007002 · Cited by 172
Roth, C., Wilken, B., Hanefeld, F., Schroter, W., & Leonhardt, U. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380089 · Cited by 160
Hypothalamic regulation of energy homeostasis
Sainsbury, A., Cooney, G. J., & Herzog, H. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0230 · Cited by 143
Cardiovascular disease and risk factors in adults with hypopituitarism
Beshyah, S., & Johnston, D. G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00682.x · Cited by 119
Ichikawa, T. (2003) · Gut · doi:10.1136/gut.52.6.914 · Cited by 108
Acute severe steatohepatitis related to prednisolone therapy
Dourakis, S. P., Sevastianos, V., & Patsiaoura, K. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05644.x · Cited by 89
Hypothalamic Obesity: The Sixth Cranial Endocrinopathy
Lustig, R. H. (2002) · The Endocrinologist · doi:10.1097/00019616-200205000-00008 · Cited by 81
Hypothalamic obesity in humans: what do we know and what can be done?
Pinkney, J. H., Wilding, J. P. H., Williams, G., & MacFarlane, I. A. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00052.x · Cited by 74
Elevated leptin concentrations in growth hormone‐deficient hypopituitary adults
Al-Shoumer, K. A. S., Anyaoku, V., Richmond, W., & Johnston, D. G. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2131054.x · Cited by 70
Jeffcoate, W. J. (2002) · Drug Safety · doi:10.2165/00002018-200225030-00005 · Cited by 58
Growth hormone plasma levels in nonalcoholic fatty liver disease
Lonardo, A., Loria, P., Leonardi, F., Ganazzi, D., & Carulli, N. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05641.x · Cited by 43
Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly
Hennessey, J. V., & JACKSON, I. M. D. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80338-6 · Cited by 43
Influence of obesity and body fat distribution on growth hormone kinetics in humans
Langendonk, J. G., Meinders, A. E., Burggraaf, J., Frölich, M., Roelen, C. A. M., Schoemaker, R. C., Cohen, A. F., & Pijl, H. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e824 · Cited by 42
Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency
Özbey, N., Algün, E., Turgut, A. S., Orhan, Y., Sencer, E., & Molvalilar, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801206 · Cited by 27
Mersebach, H., Svendsen, O. L., Holst, J. J., Astrup, A., & Feldt‐Rasmussen, U. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01675.x · Cited by 22
Growth Hormone Replacement Therapy and Insulin Sensitivity
Svensson, J., & Bengtsson, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030218 · Cited by 21
Obesity Associated Insulin Resistance Occurs in Hypopituitary Subjects
Page, R. C., Lévy, J., & Turner, R. C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00369.x · Cited by 5
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Vos, M. B., Abrams, S. H., Barlow, S. E., Caprio, S., Daniels, S. R., Kohli, R., Mouzaki, M., Sathya, P., Schwimmer, J. B., Sundaram, S. S., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001482 · Cited by 1,008
Metadata
- Authors
- Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P.
- Venue
- Hepatology
- Published
- 2004-04
- Volume
- 39
- Issue
- 4
- Pages
- 909-914
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1998352351
- Cited by
- 252
- References
- 29
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.